广西医科大学学报JOURNALOFGUANGXIMEDICALUNIVERSITY2023Jan；40（1）广西医疗机构抗肿瘤药物分级管理专家共识*广西药学会循证药学专业委员会摘要抗肿瘤药物分级管理是规范抗肿瘤药物临床使用管理,提高合理用药水平的核心环节。国家卫生健康委员会发布的《抗肿瘤药物临床应用管理办法（试行）》要求各地制定本区域内的抗肿瘤药物分级管理目录。此外，《抗肿瘤药物临床合理应用管理指标（2021年版）》也需要各地区有一个统一的分级管理目录。基于此，广西药学会循证药学专业委员会组织多学科专家对抗肿瘤药物的分级管理目录、处方权限等热点内容进行研讨，结合广西实际，最终形成专家共识，为广西区内医疗机构做好抗肿瘤药物的分级管理提供指导。关键词抗肿瘤药物；分级管理；专家共识中图分类号：R194.2文献标志码：A文章编号：1005-930X（2023）01-0166-07DOI：10.16190/j.cnki.45-1211/r.2023.01.026Expertconsensusonclassificationmanagementofantineoplasticdrugsinguangximedicalin⁃stitutionsEvidence-basedPharmacyProfessionalCommitteeofGuangxiPharmaceuticalAssociationAbstractGradedmanagementofantineoplasticdrugsisthecorelinktoregulatethemanagementofclinicaluseofantineoplasticdrugsandimprovethelevelofrationaldruguse.“TheAdministrativeMeasuresfortheClin-icalApplicationofAntineoplasticDrugs(Trial)”issuedbytheNationalHealthCommissionofthePeople'sRe-publicofChinarequireseachregiontoformulateagradedmanagementcatalogofantineoplasticdrugsinthere-gion.Inaddition,“theManagementIndicatorsfortheRationalClinicalUseofAntineoplasticDrugs(2021Edi-tion)”alsorequiresaunifiedgradedmanagementcatalogforeachregion.Basedonthis,theEvidence-basedPhar-macyProfessionalCommitteeofGuangxiPharmaceuticalAssociationorganizedmultidisciplinaryexpertstodis-cussthehottopicssuchasthegradedmanagementcatalogofantineoplasticdrugsandprescriptionauthority,andfinallyformedanexpertconsensusincombinationwiththerealityofGuangxi,soastoprovideguidanceforthegradedmanagementofantineoplasticdrugsinmedicalinstitutionsinGuangxi.Keywordsantineoplasticdrugs;gradedmanagement;expertconsensus*基金项目：国家自然科学基金资助项目（No.82060801）；广西医科大学第一附属医院临床研究攀登计划...
